Abstracts by keywords: quality of medicare
The idea behind the introduction of individual contractual elements such as drug discount agreements into the statutory health insurance system is to initiate quality and performance competition between the health insurance companies. The necessary basic prerequisite for this competition to function is performance differentiation and the perception of these differences by the consumer. Only then can the insured represent a demand-side corrective for the competitive result through their health insurance choices. The answers to a current population survey by the Allensbach Institute for Demoscopy show that these requirements are not met and that expectations with regard to the quality of the services offered and the quality of care are hardly justified. The prospects of eliminating existing information deficits on the consumer side through targeted communication strategies must be assessed differently for the different supply areas.